Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,235,318
-
Share change
-
+5,061,105
-
Total reported value
-
$30,600,000
-
Price per share
-
$2.99
-
Number of holders
-
24
-
Value change
-
+$15,254,008
-
Number of buys
-
17
-
Number of sells
-
7
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q2 2016
As of 30 Jun 2016,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,235,318 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Knoll Capital Management, LP, Cormorant Asset Management, LLC, VANGUARD GROUP INC, DAFNA Capital Management LLC, Ghost Tree Capital, LLC, Raymond James Financial Services Advisors, Inc., BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.